Bayer

Sevabertinib (BAY 2927088) granted FDA Priority Review for the treatment of patients with HER2-mutant non-small cell lung cancer

28 May 2025

AskBio Announces Publication of Complete Results of Phase 1b Trial of AB-1005 Gene Therapy in Participants with Parkinson’s Disease in Movement Disorders

27 May 2025

AskBio Presents Complete Results of Phase 1 Trial of AB-1002 Gene Therapy in Participants with Congestive Heart Failure at European Society of Cardiology Heart Failure Meeting

27 May 2025

Bayer AG First Quarter 2025 Results and Media Update

13 May 2025

Bayer confirms 2025 targets after solid start to the year

13 May 2025

Articles tagged with 'unternehmen' | Bayer

13 May 2025

Bayer to focus production, research and development of its Crop Science division in Germany on strategic technologies

12 May 2025

Aflibercept 8 mg to treat macular edema following retinal vein occlusion submitted for approval in Japan

09 May 2025

Bayer initiates Phase I study targeting GPC3 with actinium-225 radiopharmaceutical in patients with advanced hepatocellular carcinoma

29 Apr 2025

Guru Ramamurthy appointed as new CFO for Bayer’s Crop Science Division

29 Apr 2025

View details about the software product Informachine News Trackers